Efficacy and safety of rivaroxaban in the prevention of deep vein thrombosis after hip arthroplasty

Chinese Journal of Tissue Engineering Research

Volumn 17, Issue 30, 2013, Pages 5440-5445

  Zhang, Hui ^a   Wang, Dong ^a   Sun, Hai Yu ^a   Li, Shu Wei ^a   Liu, Liang ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Artificial prosthesis; Bone and joint implants; Deep vein thrombosis; Efficacy; Heparin; Hip replacement; Rivaroxaban; Safety

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; ECCHYMOSIS; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; THROMBOSIS PREVENTION; TREATMENT DURATION;

EID: 84940340235     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2013.30.004     Document Type: Article

References (8)

1. Hunt JM, Bull TM. Clinical review of pulmonary embolism: diagnosis, prognosis, and treatment. Med Clin North Am. 2011;95(6):1203-1222.
2. Lachiewicz PF, Soileau ES. Changing indications for revision total hip arthroplasty. J Surg Orthop Adv. 2005;14(2):82-84.
3. Lieberman JR, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2005;87(9):2097-2112.
4. Parisi R, Visonà A, Camporese G, et al. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol. 2009;28(1):68-72.
5. Weitz JI, Hirsh J, Samama MM, et al. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):234S-256S.
6. Kanaan AO, Silva MA, Donovan JL, et al. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther. 2007;29(11):2395-2405.
7. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):381S-453S.
8. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135(10):858-869.